Extender PTCA catheter is indicated for the dilatation of the affected segments of a coronary artery or a coronary bypass in order to enhance myocardial perfusion. This paclitaxel-eluting balloon feature a proper coating technology which consistently delivers paclitaxel, an anti-restenotic drug during very brief inflation times, while also minimizing washout of the drug during delivery and placement of the drug-eluting balloon.   Balloon catheter offer excellent pushability, trackability and crossability due to a low balloon profile, low tip entry profile and hydrophilic coating on the distal shaft of the catheter. Paclitaxel eluting coronary balloon catheter is especially indicated for the treatment of coronary in-stent restenosis.

Major inclusion criteria

• Signed data release form
• Patients with restenotic lesion in a previously stented area of a coronary artery (irrelevant whether BMS or DES related)
• Target reference vessel diameter: 2 - 4.5 mm
• Target lesion length: 8 - 28 mm
• Target lesion stenosis: > 50 % - < 100 %

Major exclusion criteria

• Patient with allergy against appropriate anticoagulation/antiplatelet therapy

Patients with allergy against paclitaxel Patients with a target lesion that was previously treated by brachytherapy